Trials / Completed
CompletedNCT01340157
Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions
Randomized, Open Study to Assess the Impact of Two Different Types of Food on the Relative Bioavailability of Fexinidazole Tablets After Single Oral Dose in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Drugs for Neglected Diseases · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The present study is designed to assess the impact of concomitant food intake on the relative bioavailability of a single oral fexinidazole tablet administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fexinidazole | Single oral dose of 1200mg fexinidazole consisting of 2 tablets dosed at 600mg per tablet. |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2011-04-22
- Last updated
- 2017-03-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01340157. Inclusion in this directory is not an endorsement.